Isovitexin alleviates acute gouty arthritis in rats by inhibiting inflammation via the TLR4/MyD88/NF-κB pathway

References

• Aderem A, Ulevitch RJ. 2000. Toll-like receptors in the induction of the innate immune response. Nature. 406(6797):782–787.
   PubMed Web of Science ®Google Scholar
• Cai Y, Peng YH, Tang Z, Guo XL, Qing YF, Liang SH, Jiang H, Dang WT, Ma Q, He C, et al. 2014. Association of Toll-like receptor 2 polymorphisms with gout. Biomed Rep. 2(2):292–296.
   PubMedGoogle Scholar
• Chen CY, Kao CL, Liu CM. 2018. The cancer prevention, anti-inflammatory and anti-oxidation of bioactive phytochemicals targeting the TLR4 signaling pathway. Int J Mol Sci. 19(9):2729.
   PubMed Web of Science ®Google Scholar
• Hu X, Li R, Sun M, Kong Y, Zhu H, Wang F, Wan Q. 2021. Isovitexin depresses osteoarthritis progression via the Nrf2/NF-κB pathway: an in vitro study. J Inflamm Res. 14:1403–1414.
   PubMed Web of Science ®Google Scholar
• Janssens HJ, Lucassen PL, Van de Laar FA, Janssen M, Van de Lisdonk EH. 2008. Systemic corticosteroids for acute gout. Cochrane Database Syst Rev. 2(2):CD005521.
   Google Scholar
• Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 11(5):373–384.
   PubMed Web of Science ®Google Scholar
• Liu B, Huang B, Hu G, He D, Li Y, Ran X, Du J, Fu S, Liu D. 2019. Isovitexin-mediated regulation of microglial polarization in lipopolysaccharide-induced neuroinflammation via activation of the CaMKKβ/AMPK-PGC-1α signaling axis. Front Immunol. 10:2650.
   PubMed Web of Science ®Google Scholar
• Liu-Bryan R, Pritzker K, Firestein GS, Terkeltaub R. 2005a. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol. 174(8):5016–5023.
   PubMed Web of Science ®Google Scholar
• Liu-Bryan R, Scott P, Sydlaske A, Rose DM, Terkeltaub R. 2005b. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum. 52(9):2936–2946.
   PubMedGoogle Scholar
• Lv H, Yu Z, Zheng Y, Wang L, Qin X, Cheng G, Ci X. 2016. Isovitexin exerts anti-inflammatory and anti-oxidant activities on lipopolysaccharide-induced acute lung injury by inhibiting MAPK and NF-κB and activating HO-1/Nrf2 pathways. Int J Biol Sci. 12(1):72–86.
   PubMed Web of Science ®Google Scholar
• Lyu S, Ding R, Liu P, OuYang H, Feng Y, Rao Y, Yang S. 2019. LC–MS analysis of serum for the metabolomic investigation of the effects of pulchinenoside b4 administration in monosodium urate crystal-induced gouty arthritis rat model. Molecules. 24:3161.
   PubMed Web of Science ®Google Scholar
• Martin WJ, Harper JL. 2010. Innate inflammation and resolution in acute gout. Immunol Cell Biol. 88(1):15–19.
   PubMed Web of Science ®Google Scholar
• Mencherini T, Picerno P, Scesa C, Aquino R. 2007. Triterpene, antioxidant, and antimicrobial compounds from Melissa officinalis. J Nat Prod. 70(12):1889–1894.
   PubMed Web of Science ®Google Scholar
• Mitroulis I, Kambas K, Ritis K. 2013. Neutrophils, IL-1β, and gout: is there a link? Semin Immunopathol. 35(4):501–512.
   PubMed Web of Science ®Google Scholar
• Nonaka F, Migita K, Haramura T, Sumiyoshi R, Kawakami A, Eguchi K. 2014. Colchicine-responsive protracted gouty arthritis with systemic inflammatory reactions. Mod Rheumatol. 24(3):540–543.
   PubMed Web of Science ®Google Scholar
• Qing YF, Zhang QB, Zhou JG, Jiang L. 2014. Changes in Toll-like receptor (TLR)4-NFκB-IL1β signaling in male gout patients might be involved in the pathogenesis of primary gouty arthritis. Rheumatol Int. 34(2):213–220.
   PubMed Web of Science ®Google Scholar
• Raucci F, Iqbal AJ, Saviano A, Minosi P, Piccolo M, Irace C, Caso F, Scarpa R, Pieretti S, Mascolo N, et al. 2019. IL-17A neutralizing antibody regulates monosodium urate crystal-induced gouty inflammation. Pharmacol Res. 147:104351.
   PubMed Web of Science ®Google Scholar
• Sabina EP, Rasool M, Mathew L, Ezilrani P, Indu H. 2010. 6-Shogaol inhibits monosodium urate crystal-induced inflammation—an in vivo and in vitro study. Food Chem Toxicol. 48(1):229–235.
   PubMed Web of Science ®Google Scholar
• Shi Y, Evans JE, Rock KL. 2003. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 425(6957):516–521.
   PubMed Web of Science ®Google Scholar
• Simon Taylor R. 2017. BET 1: prednisolone for the treatment of acute gouty arthritis. Emerg Med J. 34(10):687–689.
   PubMed Web of Science ®Google Scholar
• So A, De Smedt T, Revaz S, Tschopp J. 2007. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther. 9(2):R28.
   PubMed Web of Science ®Google Scholar
• van Walsem A, Pandhi S, Nixon RM, Guyot P, Karabis A, Moore RA. 2015. Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis. Arthritis Res Ther. 17:66.
   PubMed Web of Science ®Google Scholar
• Wang WC, Xia YM, Yang B, Su XN, Chen JK, Li W, Jiang T. 2017. Protective effects of tyrosol against LPS-induced acute lung injury via inhibiting NF-κB and AP-1 activation and activating the HO-1/Nrf2 pathways. Biol Pharm Bull. 40(5):583–593.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Lenardo MJ, Baltimore D. 2017. 30 Years of NF-κB: a blossoming of relevance to human pathobiology. Cell. 168(1–2):37–57.
   PubMed Web of Science ®Google Scholar
• Zielińska-Pisklak MA, Kaliszewska D, Stolarczyk M, Kiss AK. 2015. Activity-guided isolation, identification and quantification of biologically active isomeric compounds from folk medicinal plant Desmodium adscendens using high performance liquid chromatography with diode array detector, mass spectrometry and multidimentional nuclear magnetic resonance spectroscopy. J Pharm Biomed Anal. 102:54–63.
   PubMed Web of Science ®Google Scholar